iSonea Limited Announces Initiation of Pediatric Asthma Study

SEVERNA PARK, Md.--(BUSINESS WIRE)--Medical technology company, iSonea Ltd. (ASX: ISN; OTCQX: ISOAY) today announced the launch of a post-market study using iSonea’s WheezoMeter™ monitoring technology. The goal of the Wheeze Rate Correlation Study is to assess wheeze rate in pediatric patients with a range of asthma symptom severity.

Back to news